We are live on
!
Find out more
Biogen
BIIB
BIIB
973 hedge funds and large institutions have $85.3B invested in Biogen in 2015 Q2 according to their latest regulatory filings, with 100 funds opening new positions, 367 increasing their positions, 348 reducing their positions, and 85 closing their positions.
New
Increased
Maintained
Reduced
Closed
18% more first-time investments, than exits
New positions opened: 100 | Existing positions closed: 85
5% more repeat investments, than reductions
Existing positions increased: 367 | Existing positions reduced: 348
1% more funds holding
Funds holding: 966 → 973 (+7)
5% less capital invested
Capital invested by funds: $90B → $85.3B (-$4.71B)
24% less funds holding in top 10
Funds holding in top 10: 68 → 52 (-16)
30% less call options, than puts
Call options by funds: $1.21B | Put options by funds: $1.72B
Holders
973
Holders Change
+7
Holders Change %
+0.72%
% of All Funds
26.22%
Holding in Top 10
52
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-23.53%
% of All Funds
1.4%
New
100
Increased
367
Reduced
348
Closed
85
Calls
$1.21B
Puts
$1.72B
Net Calls
-$507M
Net Calls Change
+$74.4M
Top Buyers
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$358M |
| 2 |
D.E. Shaw & Co
New York
|
-$306M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$249M |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$246M |
| 5 |
MCM
Marsico Capital Management
Denver,
Colorado
|
-$215M |
